货号: CL-0007
Price: ¥1600 ¥1600
生长培养基: RPMI-1640[PM150110]+10% FBS[164210]+1% P/S[PB180120]
产品信息
产品名称 | 4T1(小鼠乳腺癌细胞) |
别称 | 4T1-A |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 |
冻存液:55% 基础培养基+40% FBS+5% DMSO 温度:液氮 |
培养方案A(默认) |
生长培养基:RPMI-1640[PM150110]+10% FBS[164210]+1% P/S[PB180120] 培养条件: 气相:空气,95%;CO₂,5%, 温度:37℃ |
培养方案B(可选) |
生长培养基: 培养条件: 气相:, 温度:37℃ |
推荐传代比例 | 1:3-1:6 |
推荐换液频率 | 2-3次/周 |
参考资料(来源文献)
背景描述 | 4T1细胞是从410.4瘤株中未经诱变筛得的6-硫鸟嘌噙抗性细胞株。当4T1细胞注射到BALB/c小鼠中时,4T1细胞会自发产生高转移肿瘤,可转移到肺、肝、淋巴结和大脑,同时在注射部位形成始发灶,诱导转移时不需要摘除始发灶。4T1细胞在BALB/c小鼠中的生长与转移特性与人体中的乳腺癌十分相近,这种肿瘤是人Ⅵ期乳腺癌的动物模型。4T1细胞诱导的肿瘤在手术后及未手术情况下转移的动力学相近,可以用作手术后及未手术模型。4T1细胞诱导的肿瘤模型跟其他肿瘤模型相比,由于4T1细胞的抗6-硫鸟嘌噙特性,微小的转移细胞团(少到仅仅1个)也可以在许多远端器官中检测到,没必要数淋巴结或称重器官。 |
年龄(性别) | Female |
组织来源 | 乳腺组织 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 乳腺癌细胞 |
生物安全等级 | BSL-1 |
致瘤性 | Yes, forms tumors and metastasizes in BALB/c mice. |
STR位点信息
STR鉴定图
-
Hydroxychloroquine Platinum(IV) Conjugate Displaying Potent Antimetastatic Activities by Suppressing Autophagy to Improve the Tumor Microenvironment(2024)
作者:Linming Li, Yan Chen, Ming Zhang, Suying Li, Shuaiqi Feng, Yan-Qin He, Ning Zhang, Zhifang Liu, Meifeng Liu, Qing-Peng Wang
期刊:DALTON TRANSACTIONS
影响因子:3.5
引用产品: A549 [A-549] 细胞, 4T1 细胞, A549/DDP 细胞
-
Determination of doxorubicin in plasma and tissues of mice by UPLC-MS/MS and its application to pharmacokinetic study(2024)
作者:Zhilin Jin, Xue Xiao, Lili Gui, Qiao Lu, Jicai Zhang
期刊:Heliyon
DOI:10.1016/j.heliyon.2024.e35123
影响因子:3.4
引用产品: 4T1 细胞
-
Mechanisms of Yiai Fuzheng formula in the treatment of triple-negative breast cancer based on UPLC-Q-Orbitrap-HRMS, network pharmacology, and experimental validation(2024)
作者:Ruijie Li, Haoliang Ke, Pan Liu, Qian Yang, Yuxin Li, Longzhu Ke, Xiuping Wang, Chaoyan Wu, Yingwen Zhang
期刊:Heliyon
DOI:10.1016/j.heliyon.2024.e36579
影响因子:3.4
引用产品: NIH/3T3 细胞, NCTC 1469 细胞, 4T1 细胞, MDA-MB-231 细胞
-
Effect and mechanisms of shikonin on breast cancer cells in vitro and in vivo(2024)
作者:Yu Chuyi, Xing Haoyu, Fu Xiaguo, Zhang Yingying, Yan Xiufang, Feng Jianjia, He Zhouqin, Ru Li, Huang Chunlong, Liang Jianming
期刊:BMC Complementary Medicine and Therapies
DOI:10.1186/s12906-024-04671-3
影响因子:3.3
引用产品: 磷酸盐缓冲液(PBS) 1×, 4T1 细胞
-
Inhibitory impact of cinobufagin in triple-negative breast cancer metastasis: involvements of macrophage reprogramming through upregulated MME and inactivated FAK/STAT3 signaling(2024)
作者:Zhaohui Zhu, Hanlu Wang, Xu Qian, Meiling Xue, Aijun Sun, Yifei Yin, Jinhai Tang, Jian Zhang
期刊:Clinical Breast Cancer
DOI:10.1016/j.clbc.2024.01.014
影响因子:3.1
引用产品: MDA-MB-231 细胞, MDA-MB-468 细胞, 4T1 细胞
-
Direct introduction of cationic and anionic lipids to create pH-sensitive charge-reversible liposomes with optimized pharmacokinetics and antitumor effects(2024)
作者:Lin Ziming, Zhu Hanwen, Liu Xiaobang, Liu Pingyu, Hu Miao, Wan Panting, Dong Minzhen, Zhang Li, Xu Huae, Wang Yijun
期刊:JOURNAL OF NANOPARTICLE RESEARCH
DOI:10.1007/s11051-024-06198-7
影响因子:2.1
-
Radiosensitizer-Based injectable hydrogel for enhanced radio-chemotherapy of TNBC(2024)
作者:Jie An, Kaile Chu, Qin Zhou, Huizhu Ma, Qianwen He, YaQiong Zhang, Junping Lv, Hua Wei, Min Li, Zhifang Wu, Sijin Li
期刊:CHINESE JOURNAL OF ANALYTICAL CHEMISTRY
DOI:10.1016/j.cjac.2024.100414
影响因子:1.2
引用产品: 4T1 细胞
-
Oxyhaemoglobin saturation NIR-IIb imaging for assessing cancer metabolism and predicting the response to immunotherapy(2023)
作者:Fang Zhiguo, Wang Chenlei, Yang Jingrun, Song Zhizheng, Xie Chunyu, Ji Yu, Wang Zhongliang, Du Xiaohui, Zheng Qiang, Chen Chunying, Hu Zhiyuan, Zhong Yeteng
期刊:Nature Nanotechnology
DOI:10.1038/s41565-023-01501-4
影响因子:38.3
引用产品: 4T1 细胞, EMT6 [EMT-6] 细胞, Renca [RenCa] 细胞, LLC [LL/2; LLC1] 细胞, CT26.WT 细胞, MFC 细胞
-
Nanoscintillator-Mediated X-Ray-Triggered Boosting Transformation of Fe3+ into Fe2+ for Enhancing Tumor Ferroptosis/Immunotherapy(2023)
作者:Caiju Zhang, Shuting Lu, Kai Deng, Wang Qian, Yue Liu, Yi Li, Shiqi Jin, Ruiyang Suo, Haibo Xu, Bo Wu
期刊:ADVANCED FUNCTIONAL MATERIALS
影响因子:19.0
引用产品: 4T1 细胞
-
“Block and attack” strategy for tumor therapy through ZnO2/siRNA/NIR-mediating Zn2+-overload and amplified oxidative stress(2023)
作者:Yuping Jiang, Kai Shao, Fenglan Zhang, Tianyi Wang, Lei Han, Xiaoying Kong, Jinsheng Shi
期刊:Aggregate
DOI:10.1002/agt2.321
影响因子:18.8
引用产品: 4T1 细胞
-
Q1:为什么我看的文献里的细胞培养条件和你们官网的培养条件不一样呢?
部分细胞是会出现多种培养条件的,我们公司优先选择引种来源的培养条件以及建系者所用培养条件,出现差异的原因是不同实验室在保藏过程中更改了细胞的培养条件,为了避免细胞突然更换培养条件后不适应,建议您优先使用厂家推荐的培养条件培养。

识别码示意图